NCT00006119 2021-02-21Hydroxyurea in Treating Patients With Recurrent and/or Unresectable MeningiomaUNICANCERPhase 2 Completed
NCT00387933 2015-10-14Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaDuke UniversityPhase 1 Completed37 enrolled